Skip to main content

Animations

MJFF Publications

3271 - 3280 of 9039 Results
Title
Year
  • Year
  • 2017
  • 2017
  • 2013
  • 2011
  • 2009
  • 2011
  • 2015
  • 2015
  • 2016
  • 2014
  • Summary Details
    OPEN
    Title: The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-016-0002-0
    Citation Count: 596
  • Summary Details
    OPEN
    Title: Integrated molecular landscape of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0015-3
    Citation Count: 125
  • Summary Details
    OPEN
    Title: Atypical presentation of late‐onset Tay‐sachs disease
    Journal Name: Muscle & Nerve
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mus.24146
    Citation Count: 38
  • Expert Testimony at the Food and Drug Administration: Who Wants the Truth?
    2011
    Summary Details
    RESTRICTED
    Title: Expert Testimony at the Food and Drug Administration: Who Wants the Truth?
    Journal Name: Narrative Inquiry in Bioethics
    Publisher: Project MUSE
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1353/nib.2011.0046
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Rapid selection of cyclic peptides that reduce α-synuclein toxicity in yeast and animal models
    Journal Name: Nature Chemical Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nchembio.193
    Citation Count: 137
  • Summary Details
    OPEN
    Title: Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
    Journal Name: Nature Chemical Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nchembio.538
    Citation Count: 430
  • Summary Details
    OPEN
    Title: O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease
    Journal Name: Nature Chemistry
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nchem.2361
    Citation Count: 304
  • Summary Details
    OPEN
    Title: Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/ncomms8314
    Citation Count: 307
  • Summary Details
    OPEN
    Title: Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/ncomms10332
    Citation Count: 97
  • Summary Details
    OPEN
    Title: Objective Assessment of Fall Risk in Parkinson's Disease Using a Body-Fixed Sensor Worn for 3 Days
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0096675
    Citation Count: 221
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.